Clinical trial Recruiting at 2 sites Phase 4 Interventional Ages 18 to 80

Volatile gases versus IV propofol to protect the brain during craniotomy

Official title: Effect of Volatile-based Versus Total Intravenous Anesthesia on Cerebral Homeostasis and Neucognitive Function in Patients Undergoing Elective Craniotomy for Brain Tumor Excision.

Run by Aristotle University Of Thessaloniki · NCT06779890 · Data updated 2026-11-12

This trial tests whether using volatile anesthetics (sevoflurane or desflurane) or a propofol-based total intravenous anesthesia during craniotomy for brain tumor affects brain oxygen balance, swelling, and early thinking after surgery.

More Cerebral Oxygenation trials

Quick facts

PhasePhase 4
Study typeInterventional
Ages18 Years to 80 Years
SexAll
Enrollment84 (estimated)
SponsorAristotle University Of Thessaloniki
Academic / other
Locations2 sites (Thessaloniki and 1 other locations)
StatusRecruiting
StartedMay 12, 2025
Main results expectedSeptember 30, 2026
Study endsSeptember 30, 2026
Registry record updatedOctober 1, 2025
Trial IDNCT06779890 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with ASA physical status 1–3 scheduled for elective or semi-elective craniotomy for brain tumor resection who can give informed consent are the intended participants.

Probably not a fit

Patients with prior craniotomy at the same site, morbid obesity, preexisting delirium or cognitive impairment, significant heart block or very low heart rate, pregnancy, use of certain alpha-2 agonists, or severe liver or kidney failure are excluded and unlikely to benefit from the trial findings.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults having elective or semi-elective craniotomy for brain tumor resection receive standard induction with remifentanil and propofol and neuromuscular blockade, then are maintained with either low-flow volatile anesthesia (sevoflurane or desflurane) or propofol via target-controlled infusion. Continuous hemodynamic monitoring (ClearSight), BIS, NOL analgesia monitoring, arterial line sampling and ipsilateral jugular bulb catheterization are used to measure cerebral oxygenation, metabolic markers and derived parameters at predefined time points. Protective ventilation and standardized arterial and jugular blood gas panels are applied to control physiologic variables. The study excludes patients with prior craniotomy at the same site, morbid obesity, preoperative delirium or cognitive disturbance, significant heart conduction problems, pregnancy, certain antihypertensive regimens, or liver/renal failure.

Why it matters

Potential benefit: If successful, the results could help clinicians choose the anesthesia method that better preserves brain oxygenation and reduces postoperative swelling and cognitive problems after tumor surgery.

How similar studies have gone: Prior work shows anesthetic choice can change cerebral physiology, but conclusive evidence that one approach improves postoperative cognitive outcomes after brain tumor surgery is limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* ASA-PS 1-3 (American Society of Anesthesiologists Physical Status classification)
* Elective or semi-elective craniotomy for brain tumor resection
* Signed informed consent

Exclusion Criteria:

* History of craniotomy at the same site
* Morbid obesity
* Delirious person before surgery
* Cognitive disturbances
* Preoperative heart rate (HR) \<45 beats/min or second or third degree AV block
* Treatment with a-methyldopa, clonidine or other a2-adrenergic agonist
* Pregnancy
* Liver or renal failure

Where it's running

  • AHEPA University Hospital
    Thessaloniki, Greece
    Recruiting
  • Aristotle University of Thessaloniki
    Thessaloniki, Greece
    Recruiting

Study contacts

  • Principal investigator: Georgia Tsaousi, Professor — Aristotle University Of Thessaloniki
  • Study coordinator: Georgia Tsaousi, Professor
  • Email: tsaousig@otenet.gr
  • Phone: +302310994855

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.